BTB Korea
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
BTB Korea makes aesthetic medical devices, equipment used for anti-aging and beauty treatments, and also distributes reagents and testing instruments through a wholesale and retail operation.
Its products serve the medical-device and biotech supply chain. The company operates two distinct divisions: a medical-device unit focused on manufacturing aesthetic equipment, and a bio unit handling distribution of reagents and testing tools. It is listed on KOSDAQ, South Korea's tech and small-cap stock exchange.
Summary is AI-generated and may contain errors · figures from DART filings
The current company was formed when GTG Wellness absorbed Dongin Biotech through a court-supervised restructuring merger, then rebranded as BTB Korea.
BTB Korea in five facts
What does BTB Korea do?
BTB Korea makes aesthetic medical devices, equipment used for anti-aging and beauty treatments, and also distributes reagents and testing instruments through a wholesale and retail operation.
Where is BTB Korea listed and in which sector?
BTB Korea (Korean name: 한국비티비) trades under KRX code 219750 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is BTB Korea?
Its market capitalisation was US$24.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were BTB Korea's latest annual revenue and operating profit?
For fiscal year 2025, BTB Korea reported revenue of US$24.2M, an operating loss of US$2.2M and a net loss of US$3M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 6.3% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Trading suspension (share consolidation/split registration)M&A · Jun 1
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
BTB Korea reported separate results for FY2025: revenue of US$22.2M (+6.3% year on year), an operating loss of US$1.98M (from a profit a year earlier) and a net loss of US$2.73M.
Earnings · Feb 25